33821-72-6

Basic information

• Product Name: 9H-Pyrido[3,4-b]indole-3-methanol, 1-methyl-
• Synonyms: 3-hydroxymethylharmane
• CAS NO: 33821-72-6
• Molecular Formula: C13H12N2O
• Molecular Weight: 212.251
• Mol File: 33821-72-6.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 9H-Pyrido[3,4-b]indole-3-methanol, 1-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 9H-Pyrido[3,4-b]indole-3-methanol, 1-methyl-(33821-72-6)
• EPA Substance Registry System: 9H-Pyrido[3,4-b]indole-3-methanol, 1-methyl-(33821-72-6)

Safety Data

• Hazardous Substances Data: 33821-72-6(Hazardous Substances Data)

Upstream product

• 22329-38-0 harman-3-carboxylic acid 
• 54-12-6 Trp 
• 191279-38-6 (3S)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester 
• 7303-49-3 DL-tryptophan methyl ester 
• 191279-37-5 (3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid 
• 191279-39-7 ethyl 1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylate 
• 73-22-3 L-Tryptophan 
• 33821-71-5 ethyl 1-methyl-9H-pyrido[3,4-b]indole-3-carboxylateyl-2,3,4,9-tetrahydro-1Hpyrido[3,4-b]indole-3-carboxylate 
• 55857-67-5 ethyl (1S,3S)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate 
• 40678-46-4 (1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid 
• 16108-10-4 1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester 
• 5470-37-1 1-methyl-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid 
• 689303-12-6 1-(dichloromethyl)-9H-β-carboline-3-carboxylic acid 
• 689303-18-2 methyl 1-(dichloromethyl)-9H-β-carboline-3-carboxylate 

Downstream Products

• 777062-70-1 1-methyl-9H-pyrido[3,4-b]indole-3-carbaldehyde 
• 63885-91-6 (1-methyl-9H-pyrido[3,4-b]indol-3-yl)methanamine 

Relevant articles and documents

Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy

Overexpression of histone deacetylases (HDACs) are observed in different types of cancers, but histone deacetylase inhibitors (HDACIs) have not shown significant efficacy as monotherapy against solid tumors. Recently, studies demonstrated that it is promi

A class β . Preparation method and anti-tumor application

The invention discloses β -carbofuran mustard derivatives as well as a preparation method and application thereof, and belongs to the field of natural medicines and medicinal chemistry. The invention specifically relates to a preparation method of a serie

Design, synthesis, and biological evaluation of novel N-acylhydrazone bond linked heterobivalent β-carbolines as potential anticancer agents

Utilizing a pharmacophore hybridization approach, we have designed and synthesized a novel series of 28 new heterobivalent β-carbolines. The in vitro cytotoxic potential of each compound was evaluated against the five cancer cell lines (LLC, BGC-823, CT-26, Bel-7402, and MCF-7) of different origin—murine and human, with the aim of determining the potency and selectivity of the compounds. Compound 8z showed antitumor activities with half-maximal inhibitory concentration (IC50) values of 9.9 ± 0.9, 8.6 ± 1.4, 6.2 ± 2.5, 9.9 ± 0.5, and 5.7 ± 1.2 μM against the tested five cancer cell lines. Moreover, the effect of compound 8z on the angiogenesis process was investigated using a chicken chorioallantoic membrane (CAM) in vivo model. At a concentration of 5 μM, compound 8z showed a positive effect on angiogenesis. The results of this study contribute to the further elucidation of the biological regulatory role of heterobivalent β-carbolines and provide helpful information on the development of vascular targeting antitumor drugs.